XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) (NCT05881278)

🧪 Interventions in This Study

• Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS) (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (20 Sites)

• University of California San Diego — La Jolla, California
• Cedars-Sinai — Los Angeles, California
• David Geffen School of Medicine at UCLA — Los Angeles, California
• Stanford Medicine — Palo Alto, California
• Emory University — Atlanta, Georgia
• Northwestern Memorial Hospital — Chicago, Illinois
• University of Maryland Medical Center/University of Maryland, Baltimore — Baltimore, Maryland
• Johns Hopkins Medicine — Baltimore, Maryland
• Washington University - Barnes Jewish Hospital — St Louis, Missouri
• University of Nebraska Medical Center — Omaha, Nebraska
• NYU Langone Health — New York, New York
• Columbia University Irving Medical Center/New York Presbyterian Hospital — New York, New York
• Montefiore Medical Center — The Bronx, New York
• Duke University — Durham, North Carolina
• Cleveland Clinic Foundation — Cleveland, Ohio
• Ohio State University — Columbus, Ohio
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
• Vanderbilt University — Nashville, Tennessee
• UT Southwestern Medical Center — Dallas, Texas
• University of Washington Medical Center — Seattle, Washington

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Heart Failure

• REDUCE LAP-HFREF TRIAL — New York, New York
• Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
• DASH Diet in Heart Failure Outpatients — Sacramento, California
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
• LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama

Explore by condition: All Heart Failure clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.